Votubia API Insights Report 2018 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Dec 19, 2018--The “Votubia - API Insight,2018” drug pipelines has been added to ResearchAndMarkets.com’s offering.
Votubia - API Insight, 2018 report provides product and API manufacturers’ details across the globe along with the location. The report gives the clear idea on the country wise DMF filed by worldwide companies related to Votubia . The report also highlights the patent details of Votubia .
Scope of the report:A comprehensive product overview including product description, regulatory milestones, safety, pharmacological properties, clinical trials, and product development activities have been elaborated in this report Patent information around Votubia in United States (US) and Europe (EU) has been highlighted API manufacturers for Votubia in United States, Europe, China and India The report contains historical and forecasted sales for Votubia till 2020 Enlists the market competition and emerging therapies in the space where Votubia operates
Key Topics Covered:
1. Votubia Overview
2. Votubia Global Sales AssessmentVotubia Historical Global Sales Votubia Forecasted Global Sales
3. Product DescriptionMechanism of Action Pharmacodynamic Properties Pharmacokinetic Properties
4. Product Details by country
5. Patent Information
6. Global API Manufacturers AssessmentActive Pharmaceutical Ingredient (API) Manufacturers by Country Active Pharmaceutical Ingredient (API) Manufacturers by Region
For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/ff69vw/votubia_api?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20181219005735/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Oncology Drugs
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 12/19/2018 02:56 PM/DISC: 12/19/2018 02:56 PM